Principles of Chemotherapy - Experimental Oncology Graduate Study

More documents

Recommendations

Info

[3] The next generation: Rational CT?Designer drugs for the treatment <strong>of</strong> cancers with consistent molecular alterations• Can we target molecular changes, such as the bcr-ablfusion protein tyrosine kinase (PTK) that is characteristic<strong>of</strong> CML cells?The Philadelphia chromosome42
Gleevec (imatinib mesylate), formerly known as STI5743
Page 1 and 2: ONCOLOGY 520CHEMOTHERAPYLecturer: D
Page 3 and 4: Combination CT• Improvements in C
Page 5 and 6: Therapeutic Index, contd.• Such d
Page 7 and 8: Relationship between remission and
Page 9 and 10: Classes of anticancer drugs• “C
Page 11 and 12: a. Nitrogen mustards• Bifunctiona
Page 13 and 14: Melphalan (LMelphalan(L-phenylalani
Page 15 and 16: . Chloroethyl nitrosoureas• The 2
Page 17 and 18: 2. AntimetabolitesDrugs that resemb
Page 19 and 20: Antimetabolites, contd.Cytosine ara
Page 21 and 22: Natural products, contd.Actinomycin
Page 23 and 24: Natural products, contd.VP-16 and V
Page 25 and 26: 4. “Platinating” agents: Cispla
Page 27 and 28: 1. Transport• Mutation/altered ex
Page 29 and 30: Nucleoside analog responsiveness an
Page 31 and 32: 2. Glutathione and associated enzym
Page 33 and 34: 4. Tolerance to DNA damage• In ma
Page 35 and 36: 5. Drug-specific mechanisms• Ctx:
Page 37 and 38: Cell-cycle phase specificity of CT
Page 39 and 40: [2] Use of high-dose CT through ove
Page 41: Bone marrow transplantation and gen
Page 45 and 46: Hypoxic-cell cell cytotoxins: Tirap

Principles of Chemotherapy - Experimental Oncology Graduate Study

Create successful ePaper yourself

Delete template?

Save as template?